These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 7752451)
1. [Modification of vancomycin nephrotoxicity by other antibiotics in rats]. Itoh F; Sato K; Harauchi T; Hirata M; Mizushima Y Jpn J Antibiot; 1995 Mar; 48(3):380-8. PubMed ID: 7752451 [TBL] [Abstract][Full Text] [Related]
2. [Nephrotoxicity and drug interaction of vancomycin (2)]. Toyoguchi T; Nakagawa Y Nihon Yakurigaku Zasshi; 1996 May; 107(5):225-35. PubMed ID: 8690304 [TBL] [Abstract][Full Text] [Related]
3. In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine. Oktem F; Arslan MK; Ozguner F; Candir O; Yilmaz HR; Ciris M; Uz E Toxicology; 2005 Nov; 215(3):227-33. PubMed ID: 16112787 [TBL] [Abstract][Full Text] [Related]
4. [Bacteriological evaluation of combined effects of vancomycin and beta-lactams. II. Results against gram-negative rods]. Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S Jpn J Antibiot; 1993 Nov; 46(11):946-52. PubMed ID: 8309070 [TBL] [Abstract][Full Text] [Related]
5. Role of the poly(ADP-ribose)polymerase activity in vancomycin-induced renal injury. Dalaklioglu S; Tekcan M; Gungor NE; Celik-Ozenci C; Aksoy NH; Baykal A; Tasatargil A Toxicol Lett; 2010 Feb; 192(2):91-6. PubMed ID: 19833176 [TBL] [Abstract][Full Text] [Related]
6. Novel evidence suggesting an anti-oxidant property for erythropoietin on vancomycin-induced nephrotoxicity in a rat model. Cetin H; Olgar S; Oktem F; Ciris M; Uz E; Aslan C; Ozguner F Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1181-5. PubMed ID: 17880374 [TBL] [Abstract][Full Text] [Related]
7. [Bacteriological evaluation of combined effects of vancomycin and beta-lactams. I. Results against methicillin-resistant Staphylococcus aureus]. Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S Jpn J Antibiot; 1993 Nov; 46(11):939-45. PubMed ID: 8309069 [TBL] [Abstract][Full Text] [Related]
8. Difference in nephrotoxicity of vancomycin administered once daily and twice daily in rats. Konishi H; Morita Y; Mizumura M; Iga I; Nagai K J Chemother; 2013 Oct; 25(5):273-8. PubMed ID: 24070134 [TBL] [Abstract][Full Text] [Related]
9. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (3). Protective effect of latamoxef against tobramycin nephrotoxicity and its protective mechanism. Kojima R; Ito M; Suzuki Y Jpn J Pharmacol; 1986 Nov; 42(3):397-404. PubMed ID: 3820859 [TBL] [Abstract][Full Text] [Related]
10. [A study on nephrotoxicity of arbekacin and vancomycin in rats]. Niizato T; Ohnishi M; Nishiyama S; Asaoka H; Saito A Jpn J Antibiot; 1994 Jun; 47(6):664-75. PubMed ID: 8072175 [TBL] [Abstract][Full Text] [Related]
12. [Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects. (2). Protective effect of latamoxef against gentamicin nephrotoxicity]. Kojima R; Suzuki Y Nihon Yakurigaku Zasshi; 1984 Nov; 84(5):463-9. PubMed ID: 6519582 [TBL] [Abstract][Full Text] [Related]
13. Effect of cilastatin on renal handling of vancomycin in rats. Kusama M; Yamamoto K; Yamada H; Kotaki H; Sato H; Iga T J Pharm Sci; 1998 Sep; 87(9):1173-6. PubMed ID: 9724573 [TBL] [Abstract][Full Text] [Related]
14. Nephrotoxicity of vancomycin and drug interaction study with cilastatin in rabbits. Toyoguchi T; Takahashi S; Hosoya J; Nakagawa Y; Watanabe H Antimicrob Agents Chemother; 1997 Sep; 41(9):1985-90. PubMed ID: 9303398 [TBL] [Abstract][Full Text] [Related]
15. Protective effect of inactive ingredients against nephrotoxicity of vancomycin hydrochloride in rats. Hodoshima N; Nakano Y; Izumi M; Mitomi N; Nakamura Y; Aoki M; Gyobu A; Shibasaki S; Kurosawa T Drug Metab Pharmacokinet; 2004 Feb; 19(1):68-75. PubMed ID: 15499172 [TBL] [Abstract][Full Text] [Related]
16. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (4). Effects of tobramycin alone and in combination with latamoxef on the stability of rat kidney lysosomal membranes. Kojima R; Ito M; Suzuki Y Jpn J Pharmacol; 1987 Jan; 43(1):73-80. PubMed ID: 3573418 [TBL] [Abstract][Full Text] [Related]
17. [Comparative nephrotoxicity of latamoxef and other cephalosporins in rabbits. Combined administration with furosemide or tobramycin. (author's transl)]. Harada Y; Teshima K; Okamoto T Jpn J Antibiot; 1981 Dec; 34(12):1549-70. PubMed ID: 6460885 [TBL] [Abstract][Full Text] [Related]
18. [Laboratory and clinical studies of flomoxef]. Nozue N; Ueda Y; Haga T; Muraoka A; Ono Y; Nishiya H; Miyashita H Jpn J Antibiot; 1987 Oct; 40(10):1774-86. PubMed ID: 3327964 [TBL] [Abstract][Full Text] [Related]
19. Time-Dependent Alterations of Vancomycin-Induced Nephrotoxicity in Mice. Takigawa M; Masutomi H; Kishimoto Y; Shimazaki Y; Hamano Y; Kondo Y; Arai T; Lee J; Ishii T; Mori Y; Ishigami A Biol Pharm Bull; 2017; 40(7):975-983. PubMed ID: 28674262 [TBL] [Abstract][Full Text] [Related]
20. [Nephrotoxicity and drug interaction of vancomycin]. Toyoguchi T; Nakagawa Y; Watanabe H Nihon Yakurigaku Zasshi; 1996 Feb; 107(2):53-66. PubMed ID: 8721008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]